SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001221508-14-000024
Filing Date
2014-11-13
Accepted
2014-11-13 16:25:06
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 MLPH FORM 10-Q 09-30-2014 form10q_sept302014.htm 10-Q 662392
2 MLPH FORM EX 31 09-30-2014 ex311_sept302014.htm EX-31 4678
3 MLPH FORM EX 31 09-30-2014 ex312_sept302014.htm EX-31 4645
4 MLPH FORM EX 32 09-30-2014 ex32_sept302014.htm EX-32 3051
  Complete submission text file 0001221508-14-000024.txt   1964728

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE FILE - 09-30-2014 mlph-20140930.xml EX-101.INS 242803
6 XBRL SCHEMA FILE - 09-30-2014 mlph-20140930.xsd EX-101.SCH 11236
7 XBRL CALCULATION FILE - 09-30-2014 mlph-20140930_cal.xml EX-101.CAL 17226
8 XBRL DEFINITION FILE - 09-30-2014 mlph-20140930_def.xml EX-101.DEF 16269
9 XBRL LABEL FILE - 09-30-2014 mlph-20140930_lab.xml EX-101.LAB 88532
10 XBRL PRESENTATION FILE - 09-30-2014 mlph-20140930_pre.xml EX-101.PRE 62446
Mailing Address SUITE 1023 8721 SANTA MONICA BOULEVARD LOS ANGELES CA 900694507
Business Address DRUG DISCOVERY RESEARCH CENTRE 284 OXFORD STREET, LEEDERVILLE 6007 PERTH, WESTERN AUSTRALIA C3 00000 011-61-8-9443-3011
Molecular Pharmacology (USA) Ltd. (Filer) CIK: 0001191357 (see all company filings)

IRS No.: 710900799 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50156 | Film No.: 141218748
SIC: 2834 Pharmaceutical Preparations